Kadom A H, Forrester J V, Williamson T H
Ophthalmic Physiol Opt. 1986;6(3):313-5.
The effect of fluoromethalone 0.1% suspension (FML), clobetasone butyrate 0.1% (Eumovate) and betamethasone phosphate 0.1% (Betnesol) in post-operative inflammation was studied in 60 eyes (50 patients) in a randomized trial. No significant differences were noted, although two patients required higher penetration steroids than FML or Eumovate. Betnesol seemed to have a greater tendency to cause raised intraocular pressure than FML. In this series, however, the authors are unable to comment on differences between Eumovate and Betnesol.
在一项随机试验中，对60只眼（50例患者）研究了0.1%氟米龙混悬液（FML）、0.1%丁酸氯倍他松（尤卓尔）和0.1%倍他米松磷酸钠（倍诺松）对术后炎症的影响。未观察到显著差异，尽管有两名患者需要比FML或尤卓尔渗透性更高的类固醇药物。与FML相比，倍诺松似乎更易导致眼压升高。然而，在本系列研究中，作者无法对尤卓尔和倍诺松之间的差异发表评论。
